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In this article we outline information from the
Centers for Children’s Environmental Health
and Disease Prevention Research (Children’s
Centers) that have conducted studies related
to asthma. We do not include information
on sampling strategies because the goal of
the monograph is to inform the National
Children’s Study. Rather, we focus on major
issues related to the identiﬁcation of asthma,
asthma-related symptoms and end points, rele-
vant exposures, biologic markers, and follow-
up requirements.
Studies of asthmatic children and their
homes were conducted at seven Children’s
Centers. The protocols for these studies are
summarized in Table 1, and further infor-
mation is provided in the introduction to
this mini-monograph (Kimmel et al. 2005).
The birth cohort studies conducted at two
Children’s Centers are described more com-
pletely by Eskenazi et al. (2005); they are
included here because both Children’s Centers
address respiratory cross-sectional data and
outcomes. In addition, three Children’s
Centers conducted cohort studies with older
children with established asthma, and the
study at Johns Hopkins University (JHU)
included a nonasthmatic control group as a
comparator in initial observations. Four
Children’s Centers conducted intervention tri-
als, with diverse designs ranging from a ran-
domized primary prevention trial in school-age
children to formal randomized controlled
clinical trials.
Recruitment of Participants
The studies that recruited children with
asthma had key similarities (Table 1). Children
were recruited whose parents reported a history
of doctor-diagnosed asthma. Other children
were recruited as controls. There were few
exclusion criteria in most studies except for
other respiratory diseases. Because all partici-
pants in these studies were minors, the investi-
gators had to obtain informed consent from a
parent or other guardian. When recruiting
children >7 years of age, assent was obtained
from the child in addition to the consent
obtained from a parent or guardian. In the two
Children’s Centers that conducted birth
cohort studies, mothers consented to obtain
information regarding their own and their
child’s medical and exposure histories
(Eskenazi et al. 2005). In certain cases, the
study setting included prespeciﬁed areas of a
city bounded by ZIP codes or prespecified
counties. In other cases, the study setting was
deﬁned by participants seeking care at a spe-
cific clinic or medical center regardless of
where they lived.
Although three studies used local schools
(University of Iowa, JHU intervention study,
University of Michigan), most studies identi-
ﬁed the sample from a health care setting such
as health plans, emergency departments, and
physician ofﬁces. In schools, the protocol was
approved both by an institutional review
board (IRB) and by a school system IRB.
Informed consent was mailed to the parents to
be signed, and followed by a mailed question-
naire in the case of Iowa and Michigan; in the
JHU intervention study, the mailed consent
was followed by a visit from a recruiter. For
other studies, informing and recruiting poten-
tial participants included both passive and
active methods. The passive approaches
included posting study information publicly
and providing information when a potential
participant’s parent or guardian called. These
were generally less efficient in generating
interested families to participate and generally
were considered a supplement to active meth-
ods. For the studies of children, most active
recruitment consisted of generating patient
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The National Children’s Study will address, among other illnesses, the environmental causes of
both incident asthma and exacerbations of asthma in children. Seven of the Centers for Children’s
Environmental Health and Disease Prevention Research (Children’s Centers), funded by the
National Institute of Environmental Health Sciences and the U.S. Environmental Protection
Agency, conducted studies relating to asthma. The design of these studies was diverse and
included cohorts, longitudinal studies of older children, and intervention trials involving asth-
matic children. In addition to the general lessons provided regarding the conduct of clinical stud-
ies in both urban and rural populations, these studies provide important lessons regarding the
successful conduct of community research addressing asthma. They demonstrate that it is neces-
sary and feasible to conduct repeated evaluation of environmental exposures in the home to
address environmental exposures relevant to asthma. The time and staff required were usually
underestimated by the investigators, but through resourceful efforts, the studies were completed
with a remarkably high completion rate. The deﬁnition of asthma and assessment of disease sever-
ity proved to be complex and required a combination of questionnaires, pulmonary function tests,
and biologic samples for markers of immune response and disease activity. The definition of
asthma was particularly problematic in younger children, who may exhibit typical asthma symp-
toms sporadically with respiratory infections without developing chronic asthma. Medications
confounded the definition of asthma disease activity, and must be repeatedly and systematically
estimated. Despite these many challenges, the Children’s Centers successfully conducted long-
term studies of asthma. Key words: asthma, children, Children’s Centers, environmental health,
National Children’s Study, pregnancy. Environ Health Perspect 113:1430–1436 (2005).
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who met entry criteria. Study information was
then mailed directly to participants, and study
staff telephoned sometime later to determine
the family’s interest, to conﬁrm eligibility, and
to initiate the informed consent process.
Barriers to Recruitment
There were several barriers to recruitment of
children to the studies. First among these was
establishing the essential entry criterion for a
diagnosis of asthma. This was a greater issue
for those studies recruiting younger children
(JHU longitudinal cohort study, Cincinnati)
than in those focused on older children [JHU
Intervention trial, University of Southern Cali-
fornia (USC), Michigan, Iowa]. Older children
were generally identiﬁed by a diagnosis being
made by a physician and logged into the com-
puterized database from which recruitment
began. In some cases, children with typical
asthma were entered into databases with
related diagnoses such as recurrent bronchitis
or reactive airway disease, which have slightly
different codes in the International Classi-
ﬁcation of Diseases, 9th Revision [World Health
Organization (WHO) 1978]. Study staff con-
ﬁrmed the diagnosis with screening question-
naires deﬁning appropriate symptoms or with
lung function tests. Younger children, who
may have had asthmatic respiratory symptoms
only during respiratory infections, were more
difﬁcult to qualify because they had less spe-
ciﬁc answers to respiratory questionnaires and
could not perform lung function tests. In a
birth cohort study, early wheeze may be
recorded, with persistent wheeze or asthma
being defined as an outcome later in life.
However, entry criteria for the longitudinal
cohort studies that recruited younger children
used the same definition used with older
children: doctor-diagnosed asthma. In a
birth cohort study, cough or wheeze may be
recorded as an outcome, with persistent wheeze
or deﬁnable asthma used as an outcome later
in life.
An important barrier was introduced by the
need to preserve patient autonomy and privacy.
IRBs have long required investigators to accom-
modate patients listed on health care databases
who do not want to be contacted to participate
in research studies. This has usually been
accomplished by mailing an invitation letter
containing a preaddressed and stamped post-
card that families can return requesting that
they not be called. In general, this has proven to
be a minor barrier, excluding < 5% of identiﬁed
families. The recently issued Health Insurance
Portability and Accountability Act (HIPAA)
regulations have introduced additional barriers
by requiring that families give permission to use
their health information even at preliminary
stages of research (e.g., investigators having
access to the health care database to obtain lists
of children with a diagnosis of asthma). For
example, HIPAA makes it illegal to create lists
of persons with a speciﬁc diagnosis to whom to
send an introductory letter and makes the
approach used by most of these studies illegal.
Various solutions have been developed, includ-
ing having patients sign general waivers of
HIPAA privacy rights as they enroll in a health
care program or having their health care
provider recommend them to the interviewer at
the time of a health care encounter. Other
approaches have included asking asthmatic
patients or their parents who participate in
health fairs, surveys, self-management pro-
grams, or other patient care activities to indicate
in writing their willingness to participate in
future research studies and creating a list of
those who have so indicated. IRBs may approve
a HIPAA waiver, but the investigators must jus-
tify why a waiver is necessary—that is, that the
data being gathered are not sensitive, are not
able to be linked with individual identiﬁers, or
both are noninvasive and cannot be collected in
another way. This requirement also involves
clinic personnel, who are much less effective as
recruiters that are trained, motivated study staff.
Recruitment from school directories avoids
these problems because health data are not used
to identify potential subjects. One study that
recruited from schools did so by conducting a
mailed asthma screening survey of 10 school
districts (87% response rate) to identify chil-
dren with asthma (Chrischilles et al. 2004).
Another reported a 78% response rate from
9,437 mailings (Lewis et al. 2004).
The two birth cohort studies (University of
California at Berkeley, Columbia University)
recruited pregnant mothers and thus faced the
issue of participant identiﬁcation to a smaller
extent. At the time the studies were initiated,
the HIPAA regulations had not been activated,
so they did not face this issue. Were the studies
to be conducted now, recruitment of identiﬁed
pregnant mothers (with or without asthma)
would still have to comply with the HIPAA
requirements and, indeed, do so in the contin-
ued surveillance of the children.
A ﬁnal barrier when dealing with families
with lower socioeconomic status is obtaining
a reliable means to contact persons on a list.
Families move frequently (29% moved at least
once during a 1-year observation) (Swartz
et al. 2004), so the address and telephone
numbers in a database may not be current.
Additionally, as many as 25% of inner-city
families may not have telephones (Wissow
et al. 1988), and 52% may change their tele-
phone number at least once during a year of
follow-up (Swartz et al. 2004). This not only
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Table 1. Overview of asthma-related studies and intervention.
Berkeley Columbia USC JHU Michigan CCH USC JHU Iowa Michigan
Study design BC BC LC LC LC RCT RCT RCT IT RCT
Sample size 601a 861a 11,841 150 case, 298b 225 202 100 189 298b
(n) 150 control
Outcomes Respiratory Respiratory Asthma Asthma Asthma Asthma Asthma Asthma Asthma Asthma
symptoms, symptoms, symptoms symptoms, symptoms, symptoms, symptoms, symptoms, symptoms, symptoms,
atopy, PFT, medications, PEFR medications, medications, medications, health care medications,
medications, medications, PEFR, health health care health care health care use, health care
health care health care care use use, child use use, FEV1 management use, PEFR,
use use behavior behaviors FEV1
Exposures Pesticides, PM, DEP, Air PM, NO2, O3 PM ETS, dust Dust PM, NO2, O3 Dust Dust
ETS, dust PAH, ETS, pollution, (home and (ambient, allergens, allergens, (home and allergens, allergens,
allergens pesticides, dust ambient), home, social social ambient), dust endotoxin,
(home and dust, allergens, dust personal), stressors stressors dust endotoxin, ETS, social
ambient), allergens, social allergens, O3, ETS allergens, ETS stressors
dust social stressors ETS ETS
endotoxin, stressors
social stressors
Retention (%)c 86 90 78 83 67 96 77 93 76 77
Abbreviations: BC, birth cohort; CCH, Cincinnati Children’s Hospital; DEP, diesel exhaust particles; IT, intervention trial; LC, longitudinal cohort; NO2, nitrogen dioxide; O3, ozone; PAH,
polycyclic aromatic hydrocarbon; PFT, pulmonary function tests; PM, particulate matter; RCT, randomized controlled clinical trial.
aPregnant women. bThe same children were studied in the intervention trial and the longitudinal cohort in Michigan. The two studies were conducted simultaneously, with the longitudinal
observational study extending follow-up after completion of the intervention. cTime interval for retention varies across studies. makes initial contact difficult but also inter-
feres with follow-up.
Retention
As shown in Table 1, retention rates were
generally > 80% in those studies that involved
follow-up. A number of barriers had to be
overcome to achieve these high rates, including
frequent telephone number changes, residential
address changes, and general reluctance in
making follow-up appointments. The usual
solutions to the lack of telephones or frequent
changes of telephones and addresses are to
maintain frequent contacts with participants
(generally every 1–2 months), to ask families
for secondary (and tertiary) alternative contact
information, or to provide incentives to notify
the study personnel in the event of a change in
address or telephone number (Mitchell et al.
1997). Most study staff members were able
to conduct home visits even when telephone
contact strategies had proven unsuccessful.
However, families who moved without provid-
ing new contact information interfered with
this strategy as well as with follow-up home
inspections that were part of several protocols.
For some Children’s Centers, missed appoint-
ments were important barriers to retention.
Reasons for missed appointments included
inclement weather and illness among family
members needed to help transport the child,
but in many cases no explanation was pro-
vided. Some studies categorized repeated “no-
shows” as having passively withdrawn from the
study. This practical measure was necessary to
preserve study resources. Children’s Centers
that conducted the research in the homes of
subjects (i.e., did not require participants to
come to the study center) also faced appoint-
ment cancellations.
The Children’s Centers employed multi-
ple strategies to maintain contact with par-
ticipants and to encourage their continued
participation. Commonly used incentives
included cash, gift certificates, toys for the
children, food stamps, and infant car seats. A
wide variety of gifts were provided, including
T-shirts, tote bags, hats, key chains, stuffed
animals, games, and musical instruments.
These incentives were provided either at fol-
low-up visits or on successful completion of
the study. Additional incentives included
health-related devices such as peak flow
meters, spacers for metered dose inhalers, and
allergen-proof mattress and pillow covers.
One Children’s Center provided up to $200
as reimbursement for electricity costs incurred
during the study. The Columbia Children’s
Center, faced with participants who moved to
a new location (e.g., Florida), paid for air
travel to do follow-up assessments, and in one
case a research worker has flown to the
Dominican Republic to obtain follow-up
data. The Berkeley Children’s Center created
a movable laboratory in a recreation vehicle
and went on the road once a year to other
areas in California to include participants
who moved. Another common incentive was
to provide reimbursement for travel expenses
related to study participation.
In some cases, the incentives had no mon-
etary value but focused on information pro-
vided to the family. In the JHU cohort study,
participants learned about home environmen-
tal measurements, including allergens and
pollutants; many of these families indicated
that this was the principal incentive that
attracted them to the study. All investigators
felt that the most important factor in partici-
pant retention was the Children’s Centers’
staffs. Retention was highest when the staff
members were able to create an empathetic
bond with the participating families, who felt
that the staff would try to help them not only
with their child’s illness but also with other
difficulties associated with their social and
economic circumstances. Families frequently
sought help with problems such as transporta-
tion, referrals, and problems of daily living
and valued the “ear” provided by the staff
regardless of whether the staff member could
actually help with the issue.
Environmental Data
As shown in Table 2, all the Children’s
Centers employed extensive questionnaires,
collecting demographic, social, medical, and
environmental exposure data similar to those
collected in other studies. These data were
collected repeatedly during longitudinal
follow-up, although generally in abbreviated
questionnaires.
Eggleston et al.
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Table 2. Questionnaire information.
Characteristic Berkeley Columbia USC: LC JHU: LC Michigan: LC CCH USC: IT JHU: IT Iowa Michigan: IT
Collection Pregnancy, Pregnancy, Baseline, Baseline, Baseline, Baseline, Baseline, Baseline, Baseline, Baseline,
schedule birth, 6,12, 24, every 3 months yearly 3, 6 months 3, 6, 9, day 2, 3, 4, 8, 12, 16, 3, 6, 9, 12 12 months 12 months
42 months until age 24 12, 15, 18, 6, 9, 12, 20 months months
of age months; every 6 21, 24, 27, 12.5 months
months until 60 30 months
months of age
Demographics X X X X X X X X X X
Occupation X X X X X X
Housing X X X X X X X X X X
characteristics
Pesticide X X X XX
exposure
Allergen X X X X X X X X X X
exposure
Cleaning habits X X X X X X X
Social support X X X X X X X X X
Maternal X X X X X X
depression
Child diet X X X X X
Respiratory X X X X X X X X X X
symptoms
Medication use X X X X X X X X X X
Home remedies X X XX
Smoking X X X X X X X
Medical history X X X X X X X X X X
Household X X X X X X X X X X
income
Pets X X X X X X X X X X
Child care X X X X X X
Abbreviations: BC, birth cohort; CCH, Cincinnati Children’s Hospital; IT, intervention trial; LC, longitudinal cohort.Most Children’s Centers conducted ambi-
ent air sampling at one or more sites (Table 3).
In addition, all Children’s Centers conducted
home visits and in many cases conducted visits
repeatedly (see Table 4). At these visits, the
participants’ homes were formally inspected
with checklists and families provided addi-
tional information through questionnaires. In
most cases, settled dust samples were collected
and were assayed for indoor allergens; concen-
trations of endotoxin and pesticides were also
measured. Most Children’s Centers conducted
repeated measures of environmental exposures,
including inspection, settled dust sampling,
and air sampling; completion rates for these
evaluations ranged from 73 to 91%. The data
were generally used to describe exposure at the
times indicated and was compared with asthma
morbidity at these times. Because the data were
collected as several time points, time series
analyses were conducted.
Biologic Samples
The number of studies that collected blood
samples from children was remarkable
(Table 5). These samples were generally used
for radioallergosorbent tests (RAST) for spe-
cific immunoglobulin E (IgE) antibody to
supplement or replace skin tests. Prick skin
tests and RAST have been shown to correlate
well for sensitivity to inhalant allergens (Wood
et al. 1999) and food allergens (Sampson and
Albergo 1984). When blood is saved for
RAST, the investigator has the advantage of
being able to test for additional sensitivities
that were not considered at the time the study
was conducted. The speciﬁc sensitivities deter-
mined in this manner were essential both to
determine that a child was atopic and to detect
speciﬁc IgE to the indoor allergens measured
in home visits. Atopy, deﬁned as a genetic pre-
disposition to produce long-lived IgE anti-
body to environmental allergens in association
with a constellation of chronic diseases includ-
ing food allergy, eczema, allergic rhinitis, and
asthma, is the most important risk factor for
both incident asthma and asthma severity.
The combination of specific IgE to environ-
mental allergens and the presence of high con-
centrations of these allergens in the child’s
home is the strongest known risk factor for
asthma severity and morbidity (Rosenstreich
et al. 1997).
In addition to blood samples, prick–
puncture skin testing was usually done, and
samples of meconium, urine, saliva, and hair
were collected, usually to detect exposure to
Lessons learned: asthma
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Table 4. Home evaluation.
Characteristic Berkeley Columbia USC: LC JHU: LC Michigan: LC CCH USC: IT JHU: IT Iowa Michigan: IT
Collection Pregnancy, Pregnancy, For subsample, Baseline, Baseline, Baseline, Baseline, Baseline Baseline, Baseline,
schedule 6, 12, 24,  12, 24 months one time 3, 6 months 12, 24 months 6, 12 months 4, 8, 12, 16, 6, 12 months 12 months 12 months
42 months 20 months
Age of house X X X X X X X
Proximity trafﬁc X X X X X X X
Proximity ﬁelds X X
Flooring type, X X X X X X X
condition
Cockroaches X X X X X X X X X
Rodents X X X X X X X X X
Mold X X X X X X X X X
Wall moisture X X X X X X X X X
Peeling paint X X X X X X
Water damage X X X X X X X X X
Pets X X X X X X X X X
Pesticide use X X X X X X
Gas stove/heater X X X X X X X X X
Cleanliness X X X X X X X
House dust X X X X X X X X X X
Allergens X X X X X X X X X X
Pesticide X X X X
Endotoxin X X X X X X
Home air Xa XX b XX X
PM10 XX b X
PM2.5 XX X b X
NO2 XX X
Ozone X X
Allergen X X X
Endotoxin X X
Nicotine X X X X
Abbreviations: BC, birth cohort; CCH, Cincinnati Children’s Hospital; IT, intervention trial; LC, longitudinal cohort; PM, particulate matter; PM2.5, PM < 2.5 µm in diameter; PM10, PM < 10 µm
in diameter.
aMold spores documented. bEvaluated at baseline and every 3 months.
Table 3. Ambient air sampling.
Sample Berkeley Columbia USC: LC JHU: LC Michigan: LC CCH JHU: IT
Collection Pregnancy, 6, Personal air during Continuous at Baseline, Baseline, 3, 6, 6, 12 months Baseline,
schedule 12 monthsand pregnancy, ambient and community site 6, 12 months 9, 12, 15, 18, 21, 6, 12 months
at community site indoor at 12 months 24, 27, 30 months
PM10 XX X X
PM2.5 XX XX X
NO2 XX X
Ozone X X X X
Mold/pollen X X
Air nicotine X
Abbreviations: BC, birth cohort; CCH, Cincinnati Children’s Hospital; IT, intervention trial; LC, longitudinal cohort; PM, particulate matter; PM2.5, PM < 2.5 µm in diameter; PM10, PM < 10 µm
in diameter. Samples were not collected in USC: IT, Iowa, and Michigan: IT.environmental tobacco smoke (ETS) and pes-
ticides. What is most remarkable is that bio-
logic samples were collected from children in
most Children’s Centers on multiple occa-
sions and that these collections did not have
noticeable impact on participant retention
rates (Table 1).
Asthma Disease Activity
All of these studies included questions regard-
ing asthma disease activity as shown in
Table 6. Assessing disease morbidity in epi-
demiologic studies of children with asthma
involves the creation of a composite of symp-
toms, health care, and medication use from
questionnaires, together with pulmonary func-
tion tests in older children (Kattan et al. 1997).
Although there is a general consensus about
asthma-associated symptoms, there is less
agreement with regard to specific questions
that provide the most appropriate assessment
of these symptoms. Major symptoms include
cough, wheeze, chest tightness, and dyspnea,
but these are quite variable day to day and
depend on exposures to specific stimuli or
“triggers” such as respiratory viruses, allergens,
or irritants such as ETS and air pollutants. It is
now generally accepted that symptoms should
be assessed over 2-week intervals and that ques-
tions be framed in terms of the number of days
during which these symptoms are experienced
rather than frequency per day or symptom
intensity. The two most widely used question-
naires were developed by the American
Thoracic Society (ATS) (Ferris 1978) and the
Children’s Health Survey for Asthma (CHSA)
(Asmussen et al. 1999).
Several scales have been created to synthe-
size the symptoms into a description of dis-
ease activity. The most commonly accepted
comes from the National Institute of Health
(NIH)’s National Asthma Education and
Prevention Program (NAEPP) (National
Heart, Lung, and Blood Institute 1997). This
scale, summarized in Table 7, was originally
intended to categorize severity in untreated
asthmatics in clinical settings but has been
used in epidemiologic studies, as well (Diette
et al. 2001). More recently, as the use of daily
medication for asthma has become more
common, the NAEPP scale has been felt to
more appropriately describe disease control
rather than severity.
Some of the Children’s Centers included
questions from the CHSA (Asmussen et al.
1999) or from the pediatric version of the
ATS questionnaire. The JHU intervention
study used the ATS questions as they had
been adapted for the Children’s Asthma
Management Program study (Szefler et al.
2000). The difference between these question-
naires is that the CHSA uses a Likert scale to
define symptom frequency in the preceding
2 weeks, whereas the other questionnaires ask
how many days the child had experienced
individual symptoms; the reliability of the
CHSA is better documented than is the case
with other questionnaires. Because of the diur-
nal variation in asthma disease activity, symp-
toms occurring at night and during the day
are always considered separately. Symptoms
occurring with exercise or on days that the
child does not have an upper respiratory tract
infection are also recorded separately.
Other aspects of asthma morbidity also
recorded in the Children’s Centers’ investiga-
tions included interference with a child’s activ-
ity (exercise, play, school, sleep), interference
with parents’ activities, and acute events. The
latter were generally deﬁned as those requiring
systemic corticosteroid use, unscheduled physi-
cian visits, visits to emergency rooms, or hospi-
talization. Because these were uncommon
events, the recall period was generally longer,
Eggleston et al.
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Table 5. Biologic samples.
Sample Berkeley Columbia JHU: LC Michigan: LC CCH USC: IT JHU: IT Michigan: IT
Blood Maternal pregnancy Cord blood, 24, 36, Baseline Baseline, Baseline,
and delivery; cord 60 months 6, 12 months 12 months
blood; 12, 24 months
Urine Maternal pregnancy Maternal pregnancy, 6 months Baseline






Skin tests X X X X X X X
RAST X X X X
Abbreviations: BC, birth cohort; CCH, Cincinnati Children’s Hospital; IT, intervention trial; LC, longitudinal cohort. Samples were not collected in USC: LC and Iowa.
Table 6. Asthma disease activity.
Characteristic Berkeley Columbia USC-LC JHU-LC Michigan-LC CCH USC-IT JHU-IT Iowa Michigan-IT
Day symptoms X X X X X X X X X
Night symptoms X X X X X X X X X
Exercise symptoms X X X X X X X X X
Activity limited X X X X X X X X
ISAAC questionsa X XX X XXX X
Quality of lifea X X XXX X
Symptom medications X X X X X X X X X X
Control medications X X X X X X X X X X
Oral steroids X X X X X X X X X X
Recall periodb 6–12 months 3–6 months 1 year Daily 2 weeks, 3 months 8 weeks 2 weeks 2 weeks 2 weeks
ED visits X X X X X X X X X X
Hospitalization X X X X X X X X X X
Recall periodc 6–12 months 3 months 1 year 3 months Daily 3 months 4 months 3 months 2 months 3 months, 1 year
FEV1 XX X X XXX X
Daily FEV1 XX X
Daily PEFR X X X X X
Allergy history X X X X X X X X
Family history X X X X X X X X
Abbreviations: BC, birth cohort; CCH, Cincinnati Children’s Hospital; ED, emergency department; IT, intervention trial; LC, longitudinal cohort.
aOne-year recall period for ISAAC, 1-week recall period for quality-of-life questions. bRecall period for symptoms, medications. cRecall period for emergency department, hospitalizations. that is, 2 months or longer, in almost all
Children’s Centers.
In the early 1990s, an international group
created ﬁve core questions regarding childhood
asthma to facilitate an international compari-
son of varying prevalence rates or severity
indices. This scale from the International
Study of Asthma and Allergy in Childhood
(ISAAC) (Asher et al. 1995) has widespread
support among epidemiologists. The ISAAC
core asthma questions were commonly
included in the asthma-speciﬁc questionnaires
used in the Children’s Centers’ studies.
Juniper et al. (1996, 2000) developed a
series of questions to assess the effect of symp-
toms on a child’s quality of life. These provide
a composite assessment of disease activity and
tend to correlate better with daily lung func-
tion measures than do symptom question-
naires. In addition, they have the advantage of
providing a single summary number that has
proven to be sensitive to change across time,
an extremely valuable property in longitudinal
cohort studies and interventions.
Pulmonary function tests are important
measures of disease activity but correlate mod-
estly with reported symptoms or other meas-
ures of morbidity. Daily measures usually are
limited to peak expiratory flow rate (PEFR),
although forced expiratory volume in 1 sec
(FEV1) may also be measured by portable
spirometers. Children, parents, and staff must
be trained in the use of these devices; most
preschool children given training can perform
accurate PEFR measures. With proper coach-
ing, 83% of children 3–6 years of age can com-
plete technically acceptable and reproducible
maneuvers (Eigen et al. 2001); the Children’s
Center’s experience with technically acceptable
data ranged from 52 to 99%.
Medication use both modiﬁes symptoms
and provides an independent measure of
disease morbidity. Medications that are taken
to reverse symptoms of obstruction [“reliev-
ers” is the term used in the NIH consensus
guidelines (National Heart, Lung, and Blood
Institute 1997)] are recorded as equivalent to
symptoms during a day. Medications that are
taken daily [“controllers” in the NIH con-
sensus guidelines (National Heart, Lung, and
Blood Institute 1997)] may modify symp-
toms, as may medications taken before exer-
cise or other stimuli to prevent attacks. In this
setting, it is appropriate to talk about disease
“control” rather than “morbidity.” Validated
scales have been published to describe disease
control in adults (Nathan et al. 2004).
Diaries can potentially give more accurate
records of disease activity, but retrieval and
consistency are problematic. Diaries and peri-
odic questionnaires generally correlate well
(Gold et al. 1989), and the studies conducted
in the Children’s Centers used repeated ques-
tionnaires to avoid the logistical problems of
diary retrieval and data veriﬁcation.
Interventions
Five of the Children’s Centers conducted inter-
ventions to test the efﬁcacy of environmental
control measures on improving indoor envi-
ronmental exposures and asthma-related
health. Strategies employed are summarized in
Table 8. Although all Children’s Centers
emphasized an environmental education pro-
gram for families, they varied in the breadth
and intensity of other components of the inter-
vention programs. Some Children’s Centers
focused on strategies targeting a few key trig-
gers, whereas others chose a more comprehen-
sive approach. In addition, some Children’s
Centers chose to supplement home environ-
mental strategies with education for families
on asthma management, or education targeting
physicians treating the asthmatic children.
The relative benefits and challenges of these
various strategies remain the subject of intense
investigation.
Local Variations
Although childhood asthma is an issue of
national and international significance, it is
important to remember that it occurs within a
local context. Cultural, social, and linguistic
factors vary by location, as do systems of health
care and community resources. Sources of
environmental exposure, housing stock, and
population behavior patterns relative to the
exposure may vary tremendously. In addition,
historical relationships between academia and
local communities may range from strained to
quite cooperative. Each of these factors inﬂu-
ences the way asthma studies and interventions
can be practically implemented in any given
location. Some of the variation seen in study
design between Children’s Centers is a direct
result of variation in local priorities, circum-
stances, and resource constraints. What may
work in one setting may not be feasible or rele-
vant in another. Each of the Children’s Centers
described here used a community-based partici-
patory research approach (Israel et al. 2005) in
which community partners contributed signiﬁ-
cantly to the research process. The Children’s
Centers universally report that the involvement
by community members enhanced their ability
to accomplish their research goals. Multicenter
studies, such as the proposed National
Children’s Study, have an additional challenge
of balancing the need for protocol uniformity
across sites with the very real need to adjust to
local contextual issues.
Conclusions: Lessons Learned
The experience gained in the studies conducted
by the National Institute of Environmental
Health Sciences/U.S. Environmental Protection
Agency Children’s Centers for Children’s
Environmental Health and Disease Prevention
provide important lessons for the National
Children’s Study. The lessons that speciﬁcally
relate to asthma can be summarized as follows:
• Asthma identiﬁcation requires a combination
of questionnaire and physiologic measures.
Many validated questionnaires are available
to record asthma symptoms in children; these
differ in the terms used to describe symptoms
and in the period of recall. To allow compar-
ison with previously reported data and to
allow data regarding children in the United
States to be compared with those of children
in other countries, it is advisable to include
questions from the ISAAC, the ATS, and the
CHSA in study questionnaires. In addition
to historical information, objective measures
such as spirometry, eosinophil counts in
peripheral blood or secretions, or measures of
speciﬁc IgE antibody are usually included in
deﬁnitions of asthma.
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Table 7. NAEPP asthma activity classiﬁcation.
Classiﬁcation Days with symptomsa Nights with symptomsb PEFR, FEV1 (%)c
Mild intermittent 0–1 0–1 > 80
Mild persistent > 2 2 > 80
Moderate persistent Daily Weekly < 80
Severe persistent Constant > Weekly < 60
aDays during previous 2 weeks. bNights during previous month. cMeasures as a percentage of normal predicted for age,
sex, and race.
Table 8. Interventions.
Cincinnati USC JHU Iowa Michigan
Pest control X X X X
Allergen-proof mattress covers X X X
HEPA air cleaners X
Vacuum cleaners with HEPA ﬁlters X
Cleaning supplies X X
Environmental education X X X X X
Asthma management education X X Xa
Smoking cessation X X X Xa
Physician education X
Social support and referrals X
aProvided only in a limited fashion.Eggleston et al.
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• Identification of asthma in preschool-age
children is problematic. Many children
wheeze or cough with respiratory infections
and never wheeze when they are older. These
episodes are not considered to be asthmatic,
and current methods only modestly predict
which infants with wheezing will later
develop asthma. For this reason, it is appro-
priate to classify these episodes as recurrent
wheezing illness rather than asthma and to
reserve the definition of asthma for older
children with more persistent symptoms.
• Medication confounds the assessment of
asthma symptoms and classification of dis-
ease severity. Short-acting β-adrenergic ago-
nists (SABAs) will predictably improve acute
asthma symptoms. In questionnaire histories,
it is appropriate to equate the use of these
medications with episodes of asthma; the fact
that the SABAs are often used to prevent
symptoms introduces uncertainty into this
statement. Daily controller medications are
used preventively and are currently used in
more severe cases, so the use of these medica-
tions usually indicates more severe disease;
however, the inconsistency with which these
medications are prescribed lends considerable
uncertainty to this statement.
• Recruitment and data collection in health
care settings require dedicated study staff.
The Children’s Centers found that health
care personnel in clinical settings could not
be relied on either to recruit children into
the studies or to collect outcome data. This
added to the cost of recruiting in clinical set-
tings and, in addition, added to the com-
plexity of collecting health information from
patients whose privacy was protected by
HIPAA regulations. When accessed in a
manner consistent with HIPAA guidelines,
medical records can provide useful supple-
mental information, but in most clinics and
hospitals the lack of standardized records
makes this information less useful.
• There are important longitudinal data to
be gained from cohorts of older children.
Longitudinal studies provide essential data
regarding the sequence of exposure to envi-
ronmental agents and incidence cases of
asthma. Similarly, these studies provide
important exposure response data with
regard to the sequence of asthma episodes
and environmental exposures in sympto-
matic asthma. Asthma is characteristically
variable, so repeated measures are important.
The frequency of asthmatic symptom recall
and the variability of important environ-
mental stimuli dictate how frequently these
data must be recorded. For example, daily
symptoms are best explained by environ-
mental measures made during the same days.
However, environmental samples have tradi-
tionally been collected for several (or many)
days to accommodate analytic sensitivity,
but paradoxically, it is difﬁcult to attribute
symptoms reported on some but not all days
during which the measures were made. It
also follows that sporadic events, such as
hospitalizations, are difficult to associate
with measures averaged over several months.
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